What is Envista Holdings Corporation's market cap?

Envista Holdings Corporation (NVST) has a market capitalization of $4.4B and trades on NYSE.

What is Envista Holdings Corporation's revenue and profitability?

Envista Holdings Corporation generated $2.8B in trailing twelve-month revenue with net income of $67.7M, representing a net margin of 2.4%. Gross margin stands at 54.9%, with free cash flow of $220.2M. These figures are based on the Q1 2026 filing.

Who are Envista Holdings Corporation's competitors?

Envista Holdings Corporation's key competitors include Align Technology, Inc., Dentsply Sirona Inc., Integra LifeSciences Holdings, and others. These companies compete in similar markets and product categories.

Who does Envista Holdings Corporation partner with?

Envista Holdings Corporation's notable partners include Henry Schein, Inc., Danaher Corporation.

What subsidiaries does Envista Holdings Corporation have?

Envista Holdings Corporation's subsidiaries include Nobel Biocare, Ormco, DEXIS, and others.

Where is Envista Holdings Corporation headquartered?

Envista Holdings Corporation is headquartered in United States of America and employs approximately 12,800 people. It has been publicly traded since 2019.

Envista Holdings Corporation

NVST

Envista is a global dental products company that provides a comprehensive portfolio of diagnostic, treatment, and preventive solutions for dental professionals.

Market cap

$4.39B+29.7%

Revenue$2.8B+12.2%

Net income$67.7M+106%

Free cash flow$220.2M-17.8%

EPS (diluted)$0.41+106%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

May 6, 2026

Revenue$705.5MBeat by $25.5M EPS$0.36Beat by $0.05

Read the full report

Next report

Aug 5, 2026 (In 6 days)

Revenue estimate$716.1M

EPS estimate$0.33

Financials

Q1 2026

Income statement

See full

Revenue$705.5M+14.4%

Gross profit$390.1M+16.1%

Operating income$62.5M+60.3%

Net income$38.7M+115%

EPS (diluted)$0.23+130%

Balance sheet

See full

Cash & equivalents$1.1B+0.5%

Total debt$1.6B+1.8%

Total equity$3.1B+1.4%

Total assets$5.6B+2.0%

Cash flow

See full

Operating cash flow-$3.3M-1,200%

CapEx$12.5M+112%

Free cash flow-$15.8M-182%

Valuation & ratios

Valuation

See full

Market cap$4.39B+29.7%

Enterprise value$4.89B+24.6%

P/E64.8×-0.6×

P/S1.6×+0.2×

Profitability

See full

Gross margin54.9%+0.9pp

Operating margin8.5%+4.6pp

Net margin2.4%+1.2pp

FCF margin7.8%-2.9pp

Returns & leverage

See full

Return on equity2.2%+1.1pp

Debt / equity0.5×0.0×

Current ratio2.4×+0.3×

Segments

By geography

See full

North America$364.2M+12.3%

Western Europe$184.8M+29.0%

Emerging markets$125.0M+5.2%

Other developed markets$31.5M+3.6%

By segment

See full

Specialty Products & Technologies$457.8M+14.4%

Equipment & Consumables$247.7M+14.4%

Competitors

By market cap

Solventum$14.9B+17.3%

Align Technology$12.6B-15.7%

Henry Schein$9.8B+11.5%

Envista Holdings Corporation$4.4B+27.5%

DENTSPLY SIRONA$2.7B-15.8%

IAR

Integra LifeSciences$1.5B+53.8%

Alphatec Holdings$1.4B-9.9%

3D Systems$411.6M+79.6%

By revenue growth

Alphatec Holdings+22.6%

Envista Holdings Corporation+12.2%

Henry Schein+5.6%

Align Technology+2.9%

IAR

Integra LifeSciences+1.6%

Solventum-0.5%

DENTSPLY SIRONA-1.0%

3D Systems-10.2%

By net margin

Solventum17.33%+12.8pp

Align Technology10.5%+0.2pp

3D Systems4.01%+70.8pp

Henry Schein2.95%-0.3pp

Envista Holdings Corporation2.41%+47.4pp

IAR

Integra LifeSciences-0.44%+32.4pp

Alphatec Holdings-15.93%+9.8pp

DENTSPLY SIRONA-17.06%+7.4pp

Profile

Envista is a global dental products company that provides a comprehensive portfolio of diagnostic, treatment, and preventive solutions for dental professionals. The company offers a wide range of products including dental implants, orthodontic systems, digital imaging technologies, and consumables to support clinical workflows. Its core value proposition centers on partnering with professionals to improve patient outcomes through a family of established brands and a continuous improvement methodology known as the Envista Business System.

Competitive position

Envista is one of the largest global dental products companies with leading positions in the implant, orthodontic, and digital imaging segments.

GeographiesNorth America, Western Europe, China, Emerging Markets

Customer segmentsDental Specialists, General Dental Practices, Dental Service Organizations (DSOs), Hospitals and Clinics

Business modelManufacturing, Direct-to-professional sales, Distributor-based sales, Software-as-a-Service (SaaS)

SuppliersMetallic-based component suppliers, Electronic component manufacturers, Chemical and plastics suppliers, Third-party research institutions

CustomersDental Service Organizations (DSOs), Independent dental practices, Dental laboratories, Educational and governmental entities, Third-party dental distributors

CountryUnited States of America

Listed2019

Employees12.8K

CEOPaul A. Keel

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websiteenvistaco.com

FilingsSEC EDGAR

Ask your AI about Envista Holdings Corporation.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Envista Holdings Corporation's market cap?: Envista Holdings Corporation (NVST) has a market capitalization of $4.4B and trades on NYSE.
What is Envista Holdings Corporation's revenue and profitability?: Envista Holdings Corporation generated $2.8B in trailing twelve-month revenue with net income of $67.7M, representing a net margin of 2.4%. Gross margin stands at 54.9%, with free cash flow of $220.2M. These figures are based on the Q1 2026 filing.
Who are Envista Holdings Corporation's competitors?: Envista Holdings Corporation's key competitors include Align Technology, Inc., Dentsply Sirona Inc., Integra LifeSciences Holdings, and others. These companies compete in similar markets and product categories.
Who does Envista Holdings Corporation partner with?: Envista Holdings Corporation's notable partners include Henry Schein, Inc., Danaher Corporation.
What subsidiaries does Envista Holdings Corporation have?: Envista Holdings Corporation's subsidiaries include Nobel Biocare, Ormco, DEXIS, and others.
Where is Envista Holdings Corporation headquartered?: Envista Holdings Corporation is headquartered in United States of America and employs approximately 12,800 people. It has been publicly traded since 2019.